GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

NCT00376272 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1442

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Valsartan
DRUG: Placebo

Sponsor

Gruppo di Ricerca GISSI